Anetumab

Anetumab (Anti-MSLN Antibody) is a fully humanized anti mesothelin (MSLN) IgG1 antibody. Anetumab (Anti-MSLN Antibody) can be used to synthesize the ADC molecule Anetumab ravtansine (HY-141606) . Anetumab (Anti-MSLN Antibody) can be used for the research of cancer[1].

Product Specifications

CAS Number

[1954758-84-9]

Product Name Alternative

Anti-MSLN Antibody

UNSPSC

12352203

Target

ADC Antibody; Mesothelin

Type

Inhibitory Antibodies

Related Pathways

Antibody-drug Conjugate/ADC Related; Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/anetumab.html

Purity

98.78

Solubility

10 mM in DMSO

Smiles

[Anetumab]

Molecular Weight

(143.66 kDa)

References & Citations

[1]Golfier S, et al. Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect. Mol Cancer Ther. 2014 Jun;13 (6) :1537-48.